The Pharmaceutical Administration Bureau of the Macao SAR Government and the Macau Institute for Translational Medicine and Innovation (MITMI) of the University of Macau (UM) have signed a cooperation agreement for the third-party technical assessment of propriety Chinese medicines. According to the agreement, MITMI is recognised by the bureau as a third-party technical assessment body for the registration of proprietary Chinese medicines. It can carry out technical assessments on the information of pharmacological studies, pharmacological and toxicological studies, and clinical studies submitted by applicants for the registration of proprietary Chinese medicines in Macao and issue assessment reports.

At the signing ceremony, Zhong Nanshan, member of the Chinese Academy of Engineering, director of the Guangzhou Laboratory, and chairman of the Steering Committee of MITMI, said that MITMI will contribute to Macao’s economic diversification. He hopes that, under the premise of guaranteeing the safety, efficacy, and quality control of traditional Chinese medicine (TCM), and through an evidence-based assessment system that combines TCM theories, practical experiences, and clinical trials, MITMI will facilitate the development of TCM regulations in Macao and develop the city into a bridgehead for TCM to go global. Choi Peng Cheong, president of the Pharmaceutical Administration Bureau, said that the Macao SAR Government is committed to promoting the development of TCM and health industries, as demonstrated by initiatives such as the implementation of the Law on Pharmaceutical Activities in Traditional Chinese Medicine and Registration of Proprietary Chinese Medicines. He pointed out that the commercialisation of innovative TCM is one of the entry points for promoting Macao’s health industry, adding that UM has achieved remarkable results in research and teaching of TCM and the TCM assessment reports issued by MITMI will serve as a reference for the bureau. Ge Wei, vice rector of UM, said that UM actively plays the role of a bridge between Guangdong and Macao in scientific research and industrial transformation, and facilitates the commercialisation of TCM research projects in Macao and mainland China. He hopes that MITMI will provide quality third-party technical assessments for the registration of innovative proprietary Chinese medicines.

Source: Macau Institute for Translational Medicine and Innovation
Media Contact Information:
Communications Office, University of Macau
Albee LeiTel: (853) 8822 8004
Jason LeongTel: (853) 8822 8322
Email:prs.media@um.edu.mo